TG THERAPEUTICS, INC. (TGTX) › Operating IncomeTG THERAPEUTICS, INC. (TGTX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$882.0K2012: -$26.90M2013: -$22.97M2014: -$55.72M2015: -$63.18M2016: -$78.97M2017: -$118.71M2018: -$174.40M2019: -$169.06M2020: -$273.59M2021: -$344.77M2022: -$218.32M2023: $20.63M2024: $41.93M2025: $123.32M$123.32M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$123.32M+194.1%2024$41.93M+103.2%2023$20.63M+109.5%2022-$218.32M+36.7%2021-$344.77M-26.0%2020-$273.59M-61.8%2019-$169.06M+3.1%2018-$174.40M-46.9%2017-$118.71M-50.3%2016-$78.97M-25.0%2015-$63.18M-13.4%2014-$55.72M-142.6%2013-$22.97M+14.6%2012-$26.90M-2949.4%2011-$882.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share